Table 3 Late bladder/rectal toxicity using RTOG scoring after prostate treatment using the 35 and 36.25 Gy doses for those patients with a minimum 12 month follow-up
From: Stereotactic body radiotherapy for organ-confined prostate cancer
| Â | Â | RTOG grade % (number) of patients | ||||
|---|---|---|---|---|---|---|
| Â | Total Dose | 0 | I | II | III | IV |
Late Urinary | 35 Gy | 94% (45) | 4% (2) | 2% (1) | - | - |
| Â | 36.25 Gy | 88.9% (183) | 4.8% (10) | 5.8% (12) | 0.5% (1) | - |
Late Rectal | 35 Gy | 95.8% (46) | 4.2% (2) | - | - | - |
| Â | 36.25 Gy | 91.8% (189) | 5.3% (11) | 2.9% (6) | - | - |